Laboratory hemostasis: from biology to the bench - PubMed (original) (raw)
. 2018 Jun 27;56(7):1035-1045.
doi: 10.1515/cclm-2017-1205.
Affiliations
- PMID: 29455188
- DOI: 10.1515/cclm-2017-1205
Laboratory hemostasis: from biology to the bench
Giuseppe Lippi et al. Clin Chem Lab Med. 2018.
Abstract
Physiological hemostasis is an intricate biological system, where procoagulant and anticoagulant forces interplay and preserves blood fluidity when blood vessels are intact, or trigger clot formation to prevent excessive bleeding when blood vessels are injured. The modern model of hemostasis is divided into two principal phases. The first, defined as primary hemostasis, involves the platelet-vessel interplay, whilst the second, defined as secondary hemostasis, mainly involves coagulation factors, damaged cells and platelet surfaces, where the so-called coagulation cascade rapidly develops. The activation and amplification of the coagulation cascade is finely modulated by the activity of several physiological inhibitors. Once bleeding has been efficiently stopped by blood clot formation, dissolution of the thrombus is essential to restore vessel permeability. This process, known as fibrinolysis, also develops through coordinate action of a vast array of proteins and enzymes. An accurate diagnosis of hemostasis disturbance entails a multifaceted approach, encompassing family and personal history of hemostatic disorders, accurate collection of clinical signs and symptoms, integrated with laboratory hemostasis testing. Regarding laboratory testing, a reasonable approach entails classifying hemostasis testing according to cost, complexity and available clinical information. Laboratory workout may hence initiate with some rapid and inexpensive "screening" tests, characterized by high negative predictive value, then followed by second- or third-line analyses, specifically aimed to clarify the nature and severity of bleeding or thrombotic phenotype. This article aims to provide a general overview of the hemostatic process, and to provide some general suggestions to optimally facilitate laboratory hemostasis testing.
Keywords: bleeding; blood coagulation; laboratory hemostasis; platelets; thrombosis.
Similar articles
- [Diagnostic strategies in disorders of hemostasis].
Hrachovinová I. Hrachovinová I. Vnitr Lek. 2018 Summer;64(5):537-544. Vnitr Lek. 2018. PMID: 30193524 Review. Czech. - Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders.
Bonar RA, Lippi G, Favaloro EJ. Bonar RA, et al. Methods Mol Biol. 2017;1646:3-27. doi: 10.1007/978-1-4939-7196-1_1. Methods Mol Biol. 2017. PMID: 28804815 Review. - The pathophysiology of bleeding disorders presenting as abnormal uterine bleeding.
Ewenstein BM. Ewenstein BM. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 2):770-7. doi: 10.1016/s0002-9378(96)80083-4. Am J Obstet Gynecol. 1996. PMID: 8828560 Review. - Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ. Hertfelder HJ, et al. Semin Thromb Hemost. 2005;31(4):426-40. doi: 10.1055/s-2005-916678. Semin Thromb Hemost. 2005. PMID: 16149021 - Laboratory evaluation of hemostatic disorders.
Hassouna HI. Hassouna HI. Hematol Oncol Clin North Am. 1993 Dec;7(6):1161-249. Hematol Oncol Clin North Am. 1993. PMID: 8294314 Review.
Cited by
- How we manage a high D-dimer.
Franchini M, Focosi D, Pezzo MP, Mannucci PM. Franchini M, et al. Haematologica. 2024 Apr 1;109(4):1035-1045. doi: 10.3324/haematol.2023.283966. Haematologica. 2024. PMID: 37881856 Free PMC article. Review. - Advances in haemostatic sponges: Characteristics and the underlying mechanisms for rapid haemostasis.
Nepal A, Tran HDN, Nguyen NT, Ta HT. Nepal A, et al. Bioact Mater. 2023 Apr 13;27:231-256. doi: 10.1016/j.bioactmat.2023.04.008. eCollection 2023 Sep. Bioact Mater. 2023. PMID: 37122895 Free PMC article. Review. - Chitosan-Based Hemostatic Hydrogels: The Concept, Mechanism, Application, and Prospects.
Fan P, Zeng Y, Zaldivar-Silva D, Agüero L, Wang S. Fan P, et al. Molecules. 2023 Feb 3;28(3):1473. doi: 10.3390/molecules28031473. Molecules. 2023. PMID: 36771141 Free PMC article. Review. - Effects of sample matrix in the measurement of antithrombin by LC-MS: A role for immunocapture.
Kruijt M, Smit NPM, van Ham JJ, Cobbaert CM, Ruhaak LR. Kruijt M, et al. J Mass Spectrom Adv Clin Lab. 2023 Jan 7;27:61-65. doi: 10.1016/j.jmsacl.2023.01.002. eCollection 2023 Jan. J Mass Spectrom Adv Clin Lab. 2023. PMID: 36691568 Free PMC article. - Semi-Quantitative Method of Assessing the Thrombogenicity of Biomaterials Intended for Long-Term Blood Contact.
Gawlikowski M, Major R, Mika B, Komorowski D, Janiczak K, Tkacz E, Tamulewicz A, Piaseczna N. Gawlikowski M, et al. Materials (Basel). 2022 Dec 21;16(1):38. doi: 10.3390/ma16010038. Materials (Basel). 2022. PMID: 36614378 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical